Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 2, 2000, Pages 159-165

  Piddock, Laura J V ^a   Williams, Kerstin J ^a   Ricci, Vito ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; CARBON 14; ETHAMBUTOL; GLUCOSE; POLYSORBATE 80; RESERPINE; RIFAMPICIN;

ARTICLE; BACTERIAL CELL WALL; CELL TRANSPORT; CELL VIABILITY; DRUG ACCUMULATION; DRUG EXPOSURE; MYCOBACTERIUM AURUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TEMPERATURE SENSITIVITY;

EID: 0033952249     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.2.159     Document Type: Article

References (29)

1. Bloom, B. R. (1992). Tuberculosis. Back to a frightening future. Nature 358, 538-9.
2. Snider, G. L. (1997). Tuberculosis then and now: a personal perspective on the last 50 years. Annals of Internal Medicine 126, 237-43.
3. Duncan, K. (1997). Tuberculosis: Annual update. Experimental Opinion and Therapeutic Patents 7, 129-37.
4. Mitchison, D. A. (1992). The Garrod Lecture. Understanding the chemotherapy of tuberculosis - current problems. Journal of Antimicrobial Chemotherapy 29, 477-93.
5. Cole, S. T. (1994). Mycobacterium tuberculosis: drug-resistance mechanisms. Trends in Microbiology 2, 411-5.
6. Rastogi, N. & David, H. L. (1993). Mode of action of anti-tuberculosis drugs and mechanisms of drug resistance in M. tuberculosis. Research Microbiology 144, 133-43.
7. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M. J. et al. (1993). Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-50.
8. Yamada, T., Nagata, A., Ono, Y., Suzuki, Y. & Yamanouchi, T. (1985). Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 27, 921-4.
9. Ohno, H., Koga, H., Kohno, S., Tashiro, T. & Hara, K. (1996). Relationship between rifampicin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrobial Agents and Chemotherapy 40, 1053-6.
10. Brennan, P. J. & Nikaido H. (1995). The envelope of mycobacteria. Annual Reviews in Biochemistry 64, 29-63.
11. David, H. L., Clavel-Seres, S., Clement, F. & Goh, K. S. (1987). Uptake of selected antibacterial agents in Mycobacterium avium. Zentralblatt Bakteriologie Mikrobiologie Hygiene Serie A 265, 385-92.
12. Hui, J., Gordon, N. & Kajioka, R. (1971). Permeability barrier to rifampin in mycobacteria. Antimicrobial Agents and Chemotherapy 11, 773-9.
13. Yamori, S. & Tsukamura, M. (1991). Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulphadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiology and Immunity 35, 921-6.
14. Williams, K. J. & Piddock, L. J. V. (1998). Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 42, 597-603.
15. Hetherington, S. V., Watson, A. S. & Patrick, C. C. (1995). Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrobial Agents and Chemotherapy 39, 2164-6.
16. Jarlier, V. & Nikaido, H. (1994). Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiology Letters 123, 11-8.
17. Deng, L., Mikusova, K., Robuck, K. G., Scherman, M., Brennan, P. J. & McNeil, M. R. (1995). Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrobial Agents and Chemotherapy. 39, 694-701.
18. Kilburn, J. O. & Greenberg, J. (1977). Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrobial Agents and Chemotherapy 11, 534-40.
19. Rastogi, N., Goh, K. S. & David, H. L. (1990). Enhancement of drug susceptibility of M. avium by inhibitors of cell envelope synthesis. Antimicrobial Agents and Chemotherapy 34, 759-64.
20. 37Ra. Antimicrobial Agents and Chemotherapy 34, 1773-6.
21. Takayama, K. & Kilburn, J. O. (1989). Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrobial Agents and Chemotherapy 33, 1493-9.
22. Kuze, F., Kurasawa, T., Bando, K., Lee, Y. & Maekawa, N. (1981). In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Reviews in Infectious Diseases 3, 885-97.
23. Masaki, S., Sugimori, G., Okamoto, A., Imose, J. & Hayashi, Y. (1990). Effect of Tween 80 on the growth of Mycobacterium avium complex. Microbiology and Immunity 34, 653-63.
24. Van Boxtel, R. M., Lambrecht, R. S. & Collins, M. T. (1990). Effects of colonial morphology and tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrobial Agents and Chemotherapy 34, 2300-3.
25. Zeller, V., Janoir, C., Kitzis, M.-D., Gutmann, L. & Moreau, N. J. (1997). Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 1973-8.
26. Banerjee, S. K., Bhatt, K., Rana, S., Misra, P. & Chakraborti, P. K. (1996). Involvement of an efflux system in mediating high-level of fluoroquinolone resistance in Mycobacterium smegmatis. Biochemical and Biophysical Research Communications 226, 362-8.
27. Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B. et al. (1996). Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proceedings of the National Academy of Sciences, USA 93, 362-6.
28. Ainsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., De Smet, K. A. L. & Martin, C. (1998). Molecular cloning and characterisation of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. Journal of Bacteriology 180, 5836-43.
29. Chandrasekaran, S. & Lalithakumari, D. (1998). Plasmidmediated rifampicin resistance in Pseudomonas fluorescens. Journal of Medical Microbiology 47, 197-200.